Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Increases Bacteroidota/Chlorobiota group - : Ipomoea batata {Purple sweet potatoes} |
👪
Effects of polysaccharides from purple sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide treated mice. Food & function (Food Funct ) Vol: 9 Issue 2 Pages: 937-950 Pub: 2018 Feb 21 Epub: Authors Tang C , Sun J , Zhou B , Jin C , Liu J , Kan J , Qian C , Zhang N , Publication Publication |
Increases Bacteroidota/Chlorobiota group - : Ipomoea batata {Purple sweet potatoes} |
👪
Anthocyanin Extracted from Purple Sweet Potato Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice by Suppressing Pyroptosis and Altering Intestinal Flora Structure. Journal of medicinal food (J Med Food ) Vol: 27 Issue 2 Pages: 110-122 Pub: 2024 Feb Epub: 2024 Jan 5 Authors Chen J , Jiang F , Xu N , Dong G , Jiang J , Wang M , Li C , Li R , Publication |
Increases Bacteroidota/Chlorobiota group - : Ipomoea batata {Purple sweet potatoes} |
👪
Three phytosterols from sweet potato inhibit MCF7-xenograft-tumor growth through modulating gut microbiota homeostasis and SCFAs secretion. Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 141 Issue Pages: 110147 Pub: 2021 Mar Epub: 2021 Jan 18 Authors Han B , Jiang P , Jiang L , Li X , Ye X , Publication |
Decreases Bacteroidota/Chlorobiota group - : Ipomoea batata {Purple sweet potatoes} |
👪
Impact of purple sweet potato (Ipomoea batatas L.) polysaccharides on the fecal metabolome in a murine colitis model. RSC advances (RSC Adv ) Vol: 12 Issue 18 Pages: 11376-11390 Pub: 2022 Apr 7 Epub: 2022 Apr 12 Authors Sun J , Liu J , Ren G , Chen X , Cai H , Hong J , Kan J , Jin C , Niu F , Zhang W , Html Article Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]